Advisory: Wrongly coded alerts on Strength Master Fintness Tech withdrawn
The alerts on Kyowa Kirin 4151.T and MEI Pharma's MEIP.O
data results from its Phase 2 study are being withdrawn as they
were incorrectly tagged to Taiwan-based, fitness equipment maker
Strength Master Fintness Tech Co Ltd 4151.TWO , an unrelated
firm.
For the correctly coded alerts on Kyowa Kirin's data
results, please click urn:newsml:reuters.com:*:nFWN2SL0VC
STORY_NUMBER: FWN2SL0J9
STORY_DATE: 30/11/2021
STORY_TIME: 12:04:12
((Bangalore.newsroom@thomsonreuters.com))
Recent news on Kyowa Kirin
See all newsFactbox: Global pharma companies that have publicly announced Trump drug pricing agreements
Factbox: Global pharma companies that have publicly announced Trump drug pricing agreements
Brief: Kyowa Kirin Announces Agreement With US Administration To Reduce Treatment Costs For Americans
Table: Kyowa Kirin 6-MTH group results (IFRS)
Brief: Kyowa Kirin Says European Commission Approves Crysvita For Infants With X-Linked Hypophosphataemia